Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes

被引：0
|
作者：
VandeWerf, F [1 ]
机构：
[1] CATHOLIC UNIV LEUVEN, DEPT CARDIOL, B-3000 LOUVAIN, BELGIUM
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年 / 78卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：210 / 213
页数：4
相关论文
共 50 条
  • [1] Glycoprotein IIb/IIIa antagonists in acute coronary syndromes
    Maree, A
    Fitzgerald, D
    HAEMATOLOGICA, 2001, 86 (11) : 45 - 48
  • [2] Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?
    Iannetta, Loredana
    Puddu, Paolo Emilio
    Cuturello, Domenico
    Saladini, Angela
    Pellicano, Mariano
    Schiariti, Michele
    CARDIOLOGY RESEARCH, 2013, 4 (01) : 1 - 7
  • [3] Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes
    Störk, T
    Fröhlich, E
    Möckel, M
    LANCET, 2001, 358 (9297): : 1996 - 1997
  • [4] Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes
    Harrington, RA
    AMERICAN HEART JOURNAL, 1999, 138 (04) : S276 - S286
  • [5] Clinical benefit of glycoprotein IIb/IIIa receptor antagonists in patients with acute coronary syndrome
    Haase, KK
    Koenig, W
    PERFUSION, 2001, 14 (02): : 56 - 60
  • [6] Comparing trials of glycoprotein IIb/IIIa receptor antagonists
    Fox, KAA
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0R) : R10 - R17
  • [7] A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes
    Holmes, Lewis E.
    Gupta, Rohan
    Rajendran, Saissan
    Luu, John
    French, John K.
    Juergens, Craig P.
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (05) : 330 - 336
  • [8] Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
    Roe, MT
    Sapp, SK
    Lincoff, AM
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2000, 67 (02) : 131 - 140
  • [9] Overview of glycoprotein IIb/IIIa clinical trials with abciximab and eptifibatide in acute coronary syndromes and percutaneous coronary intervention
    Teirstein, P
    JOURNAL OF INVASIVE CARDIOLOGY, 1999, 11 : 26C - 30C
  • [10] Gp IIb/IIIa receptor antagonists in acute coronary syndromes with no ST elevation
    Decalf, V.
    Sabbah, L.
    Lafont, A.
    Danchin, N.
    Durand, E.
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2007, 100 (12): : 1006 - 1012
12345